1.Borderline-High Mean Corpuscular Volume Levels Are Associated with Arterial Stiffness among the Apparently Healthy Korean Individuals
Korean Journal of Family Medicine 2020;41(6):387-391
Background:
High mean corpuscular volume (MCV) has been implicated in various health problems, such as anemia, liver disease, and thyroid disease. However, the clinical significance of borderline-high MCV is poorly understood in the primary care setting. This study aimed to investigate whether borderline-high MCV was related to arterial stiffness in Korean adults as measured by brachial-ankle pulse wave velocity (baPWV).
Methods:
This cross-sectional study comprised 582 participants aged >30 years who underwent routine health examinations. Borderline-high MCV was defined as over 95.0 fl (>90th percentile) after excluding participants with MCV of ≥100 fl or ≤80 fl, and high baPWV was defined as >1,600 cm/s (>90th percentile). The odds ratios (ORs) and 95% confidence intervals (CIs) for high baPWV according to borderline-high MCV were calculated using multiple logistic regression analyses after adjusting for the confounding variables.
Results:
The mean age of the study population was 47.8±11.7 years, and 56.9% of the participants were male. Compared to that in the control group, the OR (95% CI) of high baPWV in those with a borderline-high MCV was 3.68 (1.39–9.74) after adjusting for age, sex, body mass index, alcohol intake, smoking status, regular exercise, mean blood pressure, fasting plasma glucose, triglyceride, high-density lipoprotein cholesterol, C-reactive protein, γ-glutamyltransferase, uric acid, hypertension medication, and diabetes medication.
Conclusion
Borderline-high MCV was independently associated with arterial stiffness among apparently healthy Korean individuals.
2.A Case of Primary Cutaneous Perivascular Epithelioid Cell Tumor
Haneul OH ; Byeong Geun PARK ; Il-Hwan KIM
Annals of Dermatology 2023;35(Suppl1):S155-S157
3.Ear lobule reduction using a sub-antitragal groove technique in patients with angiolymphoid hyperplasia with eosinophilia on the earlobe: a case report and literature review
Yijun MOON ; Haneul KIM ; Hojin PARK
Archives of Craniofacial Surgery 2024;25(4):192-196
Angiolymphoid hyperplasia with eosinophilia (ALHE) is a rare condition characterized by nodular lesions predominantly in the head and neck region, often causing discomfort or pain. Treatment remains challenging because of its rarity and the lack of established guidelines. This report presents a case of ALHE affecting the earlobes that was successfully managed using ear lobule reduction surgery and subsequent intralesional steroid injections. A 31-year-old woman with a history of recurrent earlobe masses underwent a partial excision to avoid the loss of the earlobe. Histopathological examination confirmed Kimura disease, a variant of ALHE. Subsequent local methylprednisolone injections effectively controlled the remaining lesions, resulting in significant size reduction without notching. Various treatment modalities have been attempted for this condition; however, recurrence rates remain high. Surgical resection combined with intralesional corticosteroid injections is the preferred approach. In this case, a sub-antitragal groove technique for earlobe reduction was employed to preserve the lateral edge of the ear lobule, minimize the risk of deformity, and achieve a predictable outcome. The sub-antitragal groove technique offers an approach to reduce earlobe size without compromising aesthetics. Further research is required to elucidate the pathogenesis of ALHE and establish standardized treatment protocols for this rare condition.
4.A Case of Thrombotic Thrombocytopenic Purpura associated with Clopidogrel in a Patient with Acute Cerebral Infarction.
Jinhee PARK ; Yeongbok LEE ; Haneul PARK ; Jiwon MIN ; Yumi KO ; Young Ok KIM
Korean Journal of Medicine 2014;87(5):615-618
Clopidogrel is an antiplatelet agent prescribed widely to prevent stent thrombosis after coronary or peripheral vascular interventions and for stroke prophylaxis. The side effects of this drug include gastrointestinal symptoms, such as nausea, abdominal pain, vomiting, and bleeding. Thrombotic thrombocytopenia purpura (TTP) is a rare complication of this drug. Here, we report a case of clopidogrel-associated TTP in a patient with cerebral infarction. To our knowledge, it is first reported case of clopidogrel-associated TTP in Korea.
Abdominal Pain
;
Cerebral Infarction*
;
Hemorrhage
;
Humans
;
Korea
;
Nausea
;
Purpura
;
Purpura, Thrombotic Thrombocytopenic*
;
Stents
;
Stroke
;
Thrombocytopenia
;
Thrombosis
;
Vomiting
5.A Case of Thrombotic Thrombocytopenic Purpura associated with Clopidogrel in a Patient with Acute Cerebral Infarction.
Jinhee PARK ; Yeongbok LEE ; Haneul PARK ; Jiwon MIN ; Yumi KO ; Young Ok KIM
Korean Journal of Medicine 2014;87(5):615-618
Clopidogrel is an antiplatelet agent prescribed widely to prevent stent thrombosis after coronary or peripheral vascular interventions and for stroke prophylaxis. The side effects of this drug include gastrointestinal symptoms, such as nausea, abdominal pain, vomiting, and bleeding. Thrombotic thrombocytopenia purpura (TTP) is a rare complication of this drug. Here, we report a case of clopidogrel-associated TTP in a patient with cerebral infarction. To our knowledge, it is first reported case of clopidogrel-associated TTP in Korea.
Abdominal Pain
;
Cerebral Infarction*
;
Hemorrhage
;
Humans
;
Korea
;
Nausea
;
Purpura
;
Purpura, Thrombotic Thrombocytopenic*
;
Stents
;
Stroke
;
Thrombocytopenia
;
Thrombosis
;
Vomiting
6.Long-Term Stability of Selected Serum Biomarkers in Leftover Samples.
Borae G PARK ; Chunhwa IHM ; Yong Hak SOHN ; Eun Hye CHOI
Journal of Laboratory Medicine and Quality Assurance 2013;35(2):122-132
BACKGROUND: The purpose of this study was to assess the quality of long-term-stored leftover blood samples, and to evaluate the long-term stability of selected serum biomarkers such as proteins, enzymes, electrolytes, and tumour markers. METHODS: Stored blood samples were transferred to our biobank after being used to conduct tests for routine medical examinations in one health care institution, and were preserved at or below -70degrees C for 4 years. We analysed 24 biomarkers whose levels had been reported 4 years ago and tested them using the same analyser, reagents, and methods by utilizing an ADVIA Centaur Immunoassay System (Siemens Healthcare Diagnostics, USA) or an ADVIA 2400 Chemistry System (Siemens, USA). RESULTS: A total of 15 out of the 24 tested biomarkers showed significant differences in paired Student t-tests (P<0.01). Among them, 5 biomarkers (free T3, free T4, thyroid stimulating hormone, carcino-embryonic antigen, and alpha feto-protein) showed significant differences and high correlation coefficients (R2>0.975). Two biomarkers, creatinine and rheumatoid arthritis factor, showed no significant differences but were poorly correlated with previously analysed data. Aspartate aminotransferase, alanine aminotransferase, hepatitis B virus (HBV) surface antigen, and insulin levels were discordant according to their reference ranges. A total of 3 biomarkers, C-reactive protein, cancer antigen 125, and HBV surface antibody, showed no significant differences and good correlations without discordant data. CONCLUSIONS: Our findings showed that long-term storage for more than 4 years can result in a considerable bias for variable biomarkers. Only 3 of the 24 biomarkers evaluated were found to be stable biomarkers. Long-term storage of leftover samples is not recommended for most chemical analyses.
Alanine Transaminase
;
Antigens, Surface
;
Arthritis, Rheumatoid
;
Aspartate Aminotransferases
;
Bias (Epidemiology)
;
Biomarkers*
;
C-Reactive Protein
;
Chemistry
;
Creatinine
;
Delivery of Health Care
;
Electrolytes
;
Enzyme Stability
;
Hepatitis B virus
;
Humans
;
Immunoassay
;
Indicators and Reagents
;
Insulin
;
Methods
;
Protein Stability
;
Reference Values
;
Serum
;
Thyrotropin
7.Successfully Treated Basal Cell Carcinoma with Mohs Surgery, Diagnosing with Dermoscopy as a Primary Diagnostic Tool without Preoperative Punch Biopsy: A Report of Two Cases
Jaeyeong JEONG ; Taewoong SEUL ; Byeong-geun PARK ; Haneul OH ; Il-Hwan KIM
Korean Journal of Dermatology 2021;59(7):555-559
Basal cell carcinoma (BCC) is the most common malignant tumor of the skin, with a nearly 2-fold increase in incidence rates over the last two decades. A punch biopsy is considered the primary diagnostic tool for BCC; however, recent studies have reported favorable sensitivity and specificity of dermoscopy as a diagnostic tool for this malignancy. Diagnosis of BCC using the “Menzies criteria” was associated with high sensitivity, and surgery performed immediately after clinico-dermoscopic diagnosis was associated with a high positive predictive value.Therefore, in view of the high diagnostic accuracy, positive predictive value, and cost-effectiveness, direct surgical treatment without preoperative biopsy may serve as a primary therapeutic strategy for BCCs that present with typical clinico-dermoscopic features. We report two cases of BCC in patients who underwent successful Mohs microsurgery without preoperative biopsy, using dermoscopy as a primary diagnostic tool.
8.Successfully Treated Basal Cell Carcinoma with Mohs Surgery, Diagnosing with Dermoscopy as a Primary Diagnostic Tool without Preoperative Punch Biopsy: A Report of Two Cases
Jaeyeong JEONG ; Taewoong SEUL ; Byeong-geun PARK ; Haneul OH ; Il-Hwan KIM
Korean Journal of Dermatology 2021;59(7):555-559
Basal cell carcinoma (BCC) is the most common malignant tumor of the skin, with a nearly 2-fold increase in incidence rates over the last two decades. A punch biopsy is considered the primary diagnostic tool for BCC; however, recent studies have reported favorable sensitivity and specificity of dermoscopy as a diagnostic tool for this malignancy. Diagnosis of BCC using the “Menzies criteria” was associated with high sensitivity, and surgery performed immediately after clinico-dermoscopic diagnosis was associated with a high positive predictive value.Therefore, in view of the high diagnostic accuracy, positive predictive value, and cost-effectiveness, direct surgical treatment without preoperative biopsy may serve as a primary therapeutic strategy for BCCs that present with typical clinico-dermoscopic features. We report two cases of BCC in patients who underwent successful Mohs microsurgery without preoperative biopsy, using dermoscopy as a primary diagnostic tool.
9.Impact of the Endothelial Tight Junction Protein Claudin-5 on Clinical Profiles of Patients With COPD.
Byeong Gon KIM ; Pureun Haneul LEE ; Sun Hye LEE ; Ae Rin BAEK ; Jong Sook PARK ; Junehyuk LEE ; Sung Woo PARK ; Do Jin KIM ; Choon Sik PARK ; An Soo JANG
Allergy, Asthma & Immunology Research 2018;10(5):533-542
PURPOSE: The tight junction protein claudin-5 (CLDN5) is critical to the control of endothelial cellular polarity and pericellular permeability. The role of CLDN5 in chronic obstructive pulmonary disease (COPD) remains unclear. The aim of this study was to investigate the association between CLDN5 levels and clinical variables in patients with COPD. METHODS: In total, 30 patients with COPD and 30 healthy controls were enrolled in the study. The plasma CLDN5 level was checked in patients with stable or exacerbated COPD and in healthy controls. RESULTS: The mean plasma CLDN5 level of patients with COPD was 0.63 ± 0.05 ng/mL and that of healthy controls was 6.9 ± 0.78 ng/mL (P = 0.001). The mean plasma CLDN5 level was 0.71 ± 0.05 ng/mL in exacerbated COPD patients and 0.63 ± 0.04 ng/mL in patients with stable COPD (P < 0.05). The plasma CLDN5 level among COPD subjects was correlated with the smoking amount (r = −0.530, P = 0.001). The plasma CLDN5 level in stable COPD patients was correlated with forced expiratory volume in one second (FEV1, %pred.) (r = −0.481, P = 0.037). CONCLUSIONS: The plasma CLDN5 level was not correlated with age. CLDN5 may be involved in the pathogenesis of COPD. Further studies having a larger sample size will be needed to clarify CLDN5 in COPD.
Claudin-5*
;
Forced Expiratory Volume
;
Humans
;
Permeability
;
Plasma
;
Pulmonary Disease, Chronic Obstructive*
;
Sample Size
;
Smoke
;
Smoking
;
Tight Junctions*
10.Methacholine bronchial provocation test in patients with asthma: serial measurements and clinical significance.
Hyun Jung SEO ; Pureun Haneul LEE ; Byeong Gon KIM ; Sun Hye LEE ; Jong Sook PARK ; Junehyuck LEE ; Sung Woo PARK ; Do Jin KIM ; Choon Sik PARK ; An Soo JANG
The Korean Journal of Internal Medicine 2018;33(4):807-814
BACKGROUND/AIMS: The methacholine bronchial provocation test (MBPT) is used to detect and quantify airway hyper-responsiveness (AHR). Since improvements in the severity of asthma are associated with improvements in AHR, clinical studies of asthma therapies routinely use the change of airway responsiveness as an objective outcome. The aim of this study was to assess the relationship between serial MBPT and clinical profiles in patients with asthma. METHODS: A total of 323 asthma patients were included in this study. The MBPT was performed on all patients beginning at their initial diagnosis until asthma was considered controlled based on the Global Initiative for Asthma guidelines. A responder was defined by a decrease in AHR while all other patients were considered non-responders. RESULTS: A total of 213 patients (66%) were responders, while 110 patients (34%) were non-responders. The responder group had a lower initial PC20 (provocative concentration of methacholine required to decrease the forced expiratory volume in 1 second by 20%) and longer duration compared to the non-responder group. Members of the responder group also had superior qualities of life, compared to members of the non-responder group. Whole blood cell counts were not related to differences in PC20; however, eosinophil concentration was. No differences in sex, age, body mass index, smoking history, serum immunoglobulin E, or frequency of acute exacerbation were observed between responders and non-responders. CONCLUSIONS: The initial PC20, the duration of asthma, eosinophil concentrations, and quality-of-life may be useful variables to identify improvements in AHR in asthma patients.
Asthma*
;
Blood Cell Count
;
Body Mass Index
;
Bronchial Provocation Tests*
;
Diagnosis
;
Eosinophils
;
Forced Expiratory Volume
;
Humans
;
Immunoglobulin E
;
Immunoglobulins
;
Methacholine Chloride*
;
Respiratory Hypersensitivity
;
Smoke
;
Smoking